EVARNO Trademark

Trademark Overview


On Friday, July 26, 2013, a trademark application was filed for EVARNO with the United States Patent and Trademark Office. The USPTO has given the EVARNO trademark a serial number of 86020962. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 23, 2015. This trademark is owned by Glaxo Group Limited. The EVARNO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
evarno

General Information


Serial Number86020962
Word MarkEVARNO
Filing DateFriday, July 26, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 23, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 24, 2013

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "EVARNO" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 31, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Monday, March 23, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 23, 2015ABANDONMENT - NO USE STATEMENT FILED
Wednesday, July 16, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 14, 2014EXTENSION 1 GRANTED
Monday, July 14, 2014EXTENSION 1 FILED
Monday, July 14, 2014TEAS EXTENSION RECEIVED
Tuesday, February 18, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 24, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 24, 2013PUBLISHED FOR OPPOSITION
Wednesday, December 4, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 15, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 8, 2013ASSIGNED TO EXAMINER
Wednesday, July 31, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, July 30, 2013NEW APPLICATION ENTERED IN TRAM